Stay updated on Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA site-wide NIH notice was added announcing a website transition and explaining that some content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.5%

- Check28 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check35 days agoChange DetectedThe website footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check56 days agoChange DetectedThe latest history entry shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This change reflects a metadata update to the record history.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, and the previous v3.6.5 entry was removed. This reflects an update to the record's versioning timeline.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.